BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19293237)

  • 1. Mitochondrial changes within axons in multiple sclerosis.
    Mahad DJ; Ziabreva I; Campbell G; Lax N; White K; Hanson PS; Lassmann H; Turnbull DM
    Brain; 2009 May; 132(Pt 5):1161-74. PubMed ID: 19293237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.
    Zambonin JL; Zhao C; Ohno N; Campbell GR; Engeham S; Ziabreva I; Schwarz N; Lee SE; Frischer JM; Turnbull DM; Trapp BD; Lassmann H; Franklin RJ; Mahad DJ
    Brain; 2011 Jul; 134(Pt 7):1901-13. PubMed ID: 21705418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and investigation of mitochondria lacking cytochrome c oxidase activity in axons.
    Zambonin J; Engeham S; Campbell GR; Ziabreva I; Beadle NE; Taylor RW; Mahad DJ
    J Neurosci Methods; 2010 Sep; 192(1):115-20. PubMed ID: 20659500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients.
    Dutta R; McDonough J; Yin X; Peterson J; Chang A; Torres T; Gudz T; Macklin WB; Lewis DA; Fox RJ; Rudick R; Mirnics K; Trapp BD
    Ann Neurol; 2006 Mar; 59(3):478-89. PubMed ID: 16392116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model.
    Hogan V; White K; Edgar J; McGill A; Karim S; McLaughlin M; Griffiths I; Turnbull D; Nichols P
    J Neurosci Res; 2009 Feb; 87(2):452-9. PubMed ID: 18803300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.
    Ohno N; Chiang H; Mahad DJ; Kidd GJ; Liu L; Ransohoff RM; Sheng ZH; Komuro H; Trapp BD
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9953-8. PubMed ID: 24958879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial defects in acute multiple sclerosis lesions.
    Mahad D; Ziabreva I; Lassmann H; Turnbull D
    Brain; 2008 Jul; 131(Pt 7):1722-35. PubMed ID: 18515320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis.
    Sathornsumetee S; McGavern DB; Ure DR; Rodriguez M
    Am J Pathol; 2000 Oct; 157(4):1365-76. PubMed ID: 11021839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.
    Licht-Mayer S; Campbell GR; Canizares M; Mehta AR; Gane AB; McGill K; Ghosh A; Fullerton A; Menezes N; Dean J; Dunham J; Al-Azki S; Pryce G; Zandee S; Zhao C; Kipp M; Smith KJ; Baker D; Altmann D; Anderton SM; Kap YS; Laman JD; Hart BA'; Rodriguez M; Watzlawick R; Schwab JM; Carter R; Morton N; Zagnoni M; Franklin RJM; Mitchell R; Fleetwood-Walker S; Lyons DA; Chandran S; Lassmann H; Trapp BD; Mahad DJ
    Acta Neuropathol; 2020 Aug; 140(2):143-167. PubMed ID: 32572598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
    Schirmer L; Antel JP; Brück W; Stadelmann C
    Brain Pathol; 2011 Jul; 21(4):428-40. PubMed ID: 21114565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G; Balesar R
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE; Nichols PP; Bates D; Turnbull DM
    Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
    Campbell GR; Ziabreva I; Reeve AK; Krishnan KJ; Reynolds R; Howell O; Lassmann H; Turnbull DM; Mahad DJ
    Ann Neurol; 2011 Mar; 69(3):481-92. PubMed ID: 21446022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis.
    Licht-Mayer S; Campbell GR; Mehta AR; McGill K; Symonds A; Al-Azki S; Pryce G; Zandee S; Zhao C; Kipp M; Smith KJ; Baker D; Altmann D; Anderton SM; Kap YS; Laman JD; 't Hart BA; Rodriguez M; Franklin RJM; Chandran S; Lassmann H; Trapp BD; Mahad DJ
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12851. PubMed ID: 36181265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions.
    Young EA; Fowler CD; Kidd GJ; Chang A; Rudick R; Fisher E; Trapp BD
    Ann Neurol; 2008 Apr; 63(4):428-35. PubMed ID: 18438950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium channel expression within chronic multiple sclerosis plaques.
    Black JA; Newcombe J; Trapp BD; Waxman SG
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):828-37. PubMed ID: 17805013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.